Holger Rhinow, Eva Köppen, and Christoph Meinel: Design Prototypes as Boundary Objects in Innovation Processes. Conference Paper in the Proceedings of the 2012 International Conference on Design Research Society (DRS 2012), Bangkok, Thailand, July 2012
In our paper we focus on how design prototypes can foster communications in organizations that deal with the development of innovations. We distinguish the impact of prototypes between two different organizational levels; we first conduct the impact of prototypes at the level of organizational design teams that develop ideas and concepts for solutions. We then focus on the impact of prototypes on the level of organizational teams and departments that have not been part of the initial design phase but are responsible for further developments in the innovation process, e.g. production, financing, and marketing.
Previous research has indicated that prototypes have a significant influence on both organizational levels. Prototypes, in the best cases, can become so-called boundary objects between different domains and stakeholders and may deliver positive effects within the innovation process. However, the successful management of stakeholders in this context remains highly challenging. In this paper we want to address these difficulties as well as the current state of research in this field. We propose that a prototype does not only stand for an important design technique but should moreover be regarded as a management tool that can be integrated into a structured dialogue between stakeholders. We provide first insights on what a structured dialogue, based on prototypes, can mean and what it thereby should imply. We will synthesize prior research findings and begin to develop a concept on how to utilize prototypes as boundary objects from a management perspective.
We are an international experience design consultancy helping companies and organisations to innovate their products, services and processes by putting people and their experiences first.
Vaccine hesitancy is a top10 global health threat. Dealing with it successfully requires understanding it as a behaviour and generating a holistic view of people’s perspectives & ecosystems. This way we can identify the best opportunities for intervention. Here is Experientia’s position on vaccine hesitancy and our tailor-made support for the vaccine industry.
100&Change is a MacArthur Foundation competition for a $100 million grant to fund a single proposal that will make measurable progress toward solving a significant problem. 100&Change will select a bold proposal that promises real progress toward solving a critical problem of our time. And it will award a $100 million grant to help make […]
Then we are interested in hearing from you. We have several positions available for talented UX/UI and service designers who are passionate about creating world-class user experiences. Please see the job descriptions on our website for more information, and send us your CV with a cover letter statement about yourself, your experience, and what UX […]
Experientia is proud to have been a key participant at the Roche Innovation Summit, held at Roche headquarters in Basel Switzerland on 19 June 2018. Themed “Transforming the Healthcare Experience Together”, the summit aimed to galvanize the Roche community around the future transformation of healthcare and diagnostics. With 800 attendees from Roche and Genentech global […]
Hai una startup? Hai mai pensato ai benefici che potrebbe trarre dal Design Thinking? Questa è l’opportunità per scoprirlo! DesAlps Workshop #2: Il Design Thinking per la tua startup! Giovedì 28 giugno 2018 – dalle 9:30 alle 17:00 @ I3P | Corso Castelfidardo 30/a, Torino —– Nell’ambito del progetto europeo DesAlps, un team di esperti […]